Immix Biopharma, Inc.
IMMX
$10.97
$0.050.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,894.41% | 468.93% | 467.86% | -19.01% | -51.46% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 155.31% | 97.17% | 33.07% | -52.12% | -56.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 102.76% | 99.35% | 366.56% | 263.84% | 30.15% |
| Total Current Assets | 1,796.80% | 449.94% | 401.23% | -27.12% | -54.90% |
|
|
|||||
| Total Current Assets | 1,796.80% | 449.94% | 401.23% | -27.12% | -54.90% |
| Net Property, Plant & Equipment | 2.13% | 8.53% | 27.80% | 42.21% | 114.09% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -84.43% | 807.35% | 458.82% | 547.55% | 542.16% |
| Total Assets | 1,429.31% | 381.68% | 356.86% | -20.13% | -45.78% |
|
|
|||||
| Total Accounts Payable | -20.17% | -17.62% | 1.01% | 114.39% | 181.87% |
| Total Accrued Expenses | 17.61% | 62.52% | 40.05% | 13.87% | 120.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 57.59% | 84.96% | 113.65% | 125.36% | 45.66% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -7.07% | 13.24% | 16.39% | 65.29% | 156.53% |
|
|
|||||
| Total Current Liabilities | -7.07% | 13.24% | 16.39% | 65.29% | 156.53% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.40% | -7.95% | -7.53% | -5.96% | -6.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -7.19% | 11.20% | 13.90% | 55.66% | 122.10% |
|
|
|||||
| Common Stock & APIC | 290.64% | 122.88% | 124.38% | 16.43% | 4.53% |
| Retained Earnings | -46.31% | -43.97% | -39.24% | -33.56% | -36.67% |
| Treasury Stock & Other | 153.87% | 106.75% | 60.59% | -140.72% | -305.29% |
| Total Common Equity | 4,819.76% | 779.38% | 607.83% | -52.91% | -80.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4,819.76% | 779.38% | 607.83% | -52.91% | -80.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4,819.76% | 779.38% | 607.83% | -52.91% | -80.52% |
|
|
|||||